{"name":"Galderma Brasil Ltda.","slug":"galderma-brasil-ltda","ticker":"","exchange":"","domain":"","description":"Galderma Brasil Ltda. is a subsidiary of Galderma, a global leader in dermatology, focusing on the research, development, and commercialization of innovative skincare solutions. The company operates in Brazil, contributing to the local healthcare market with a range of dermatological products.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Adapalene-BPO Gel","genericName":"Adapalene-BPO Gel","slug":"adapalene-bpo-gel","indication":"Acne vulgaris","status":"marketed"}]}],"pipeline":[{"name":"Adapalene-BPO Gel","genericName":"Adapalene-BPO Gel","slug":"adapalene-bpo-gel","phase":"marketed","mechanism":"Adapalene-BPO is a combination topical gel that uses a retinoid (adapalene) to normalize skin cell turnover and reduce inflammation, combined with benzoyl peroxide to kill acne-causing bacteria and provide additional anti-inflammatory effects.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQSjZzRWhuUGJ2SGdfcEVVRVo5d2tnVEVSUjVQcTFUMHREV1hCRlk3ZGlnWnJoQ2Q5YXltczduSDFQTUsydlRLNVVOa2o0TXhUcUhUREozbVBaYmhNTlB2TUJuUFpmamJBSEFYcmRVQXdpUTh3dVhJOWtGNmh5cHp6TThLbnlpMV9pdzlnNG5KUHFGNm4wV21fYjRfWmE?oc=5","date":"2022-08-17","type":"pipeline","source":"openPR.com","summary":"Lip Augmentation Market Will Exhibit an Impressive Expansion - openPR.com","headline":"Lip Augmentation Market Will Exhibit an Impressive Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9aZDhleXRrMVVrZGZDSjNxQ011T1g3bVE5ODBRZllHWWRjUUVVZlhNdjBaUWFjSnhVbGNtSWxpcWlmbDRpR0FJd2NGdThJelJUWW9YYWxNUUNuZmdocUJsZzdqUWMwRThhamhTR0ZFb3RpeFA4UE5ISllqS1HSAXxBVV95cUxQYVlfUGhFZ2FrajBRdHpuVFNmd1BhdVFtcVRBbGNXQnQwM1B4UmR5bG41d1hhSGVTQ0FDSFlWVUdiUWxYUEg5aGowZ29PcjN5RmxJbEgwRWpyYWxmTzdVdi04cGhfbENMVUxGSnY1M29ZTHZHLWxBOERZYl9s?oc=5","date":"2015-10-28","type":"pipeline","source":"Fort Worth Star-Telegram","summary":"Galderma to expand in Fort Worth with research center - Fort Worth Star-Telegram","headline":"Galderma to expand in Fort Worth with research center - Fort Worth Star","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}